PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Straube, C.* ; Schmidt-Graf, F.* ; Wiestler, B.* ; Zimmer, C.* ; Meyer, B.* ; Combs, S.E.

The algorithms of adjuvant therapy in gliomas and their effect on survival.

J. Neurosurg. Sci. 63, 179-186 (2018)
Postprint DOI PMC
Open Access Green
The treatment of gliomas became more sophisticated during the last decades. As by now, adjuvant treatment after maximum safe resection is considered an important and effective treatment strategy in most gliomas, yet the decision is based on several factors. This review summarizes the available evidence for the current adjuvant treatment algorithms with a focus on the impact on the survival of glioma patients. The review is based on the current guidelines, but it also includes new insights which have not yet been included into the official guidelines.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
1.767
0.546
4
4
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Glioma ; Glioblastoma ; Oligodendroglioma ; Adjuvant Radiotherapy; Randomized Phase-iii; Glioblastoma-multiforme; Recurrent Glioblastoma; Temozolomide Chemotherapy; Radiation-therapy; Eano Guideline; Radiotherapy; Resection; Trial; Procarbazine
Sprache
Veröffentlichungsjahr 2018
HGF-Berichtsjahr 2018
ISSN (print) / ISBN 0390-5616
e-ISSN 1827-1855
Zeitschrift Journal of neurosurgical sciences
Quellenangaben Band: 63, Heft: 2, Seiten: 179-186 Artikelnummer: , Supplement: ,
Verlag Ed. Minerva Medica
Verlagsort Torino
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Radiation Medicine (IRM)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Radiation Sciences
PSP-Element(e) G-501300-001
DOI 10.23736/S0390-5616.18.04610-6
WOS ID WOS:000461852200008
Scopus ID 85062549489
PubMed ID 30421895
Erfassungsdatum 2018-12-13
[➜Korrektur melden]